A Study of BGB-A3055, Alone and in Combination With Tislelizumab in Participants With Selected Advanced or Metastatic Solid Tumors
NCT 05935098 Brief Summary This study aims to test the safety, tolerability,…
Read more arrow_forwardNCT 05935098 Brief Summary This study aims to test the safety, tolerability,…
Read more arrow_forwardNCT 05774951 Brief Summary This is a Phase III open-label study…
Read more arrow_forwardNCT 05346484 Brief Summary This is an open-label, dose-escalation, multi-center phase I…
Read more arrow_forwardNCT 06550895 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 05117476 Brief Summary CLN-619-001 is a Phase 1, open-label, multi-center study…
Read more arrow_forwardNCT 05759728 Brief Summary This study aims to determine the safety…
Read more arrow_forwardNCT 04322318 Brief Summary This phase II trial studies how well combination…
Read more arrow_forwardNCT 05279300 Brief Summary This is a first-in-human (FIH) study to evaluate…
Read more arrow_forwardNCT 06018337 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 06577025 Brief Summary The purpose of this study is to…
Read more arrow_forward